136 related articles for article (PubMed ID: 19204840)
1. Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure.
Toy H; Camuzcuoglu H; Celik H; Erel O; Aksoy N
Swiss Med Wkly; 2009 Feb; 139(5-6):76-81. PubMed ID: 19204840
[TBL] [Abstract][Full Text] [Related]
2. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
3. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
4. Assessment of paraoxonase activities in patients with knee osteoarthritis.
Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
[TBL] [Abstract][Full Text] [Related]
7. Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
Takci Z; Bilgili SG; Karadag AS; Kucukoglu ME; Selek S; Aslan M
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):367-370. PubMed ID: 24854673
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O
Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase and arylesterase activities in fibromyalgia.
Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
[TBL] [Abstract][Full Text] [Related]
11. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
13. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder.
Bulut M; Selek S; Bez Y; Karababa IF; Kaya MC; Gunes M; Emhan A; Aksoy N; Sir A
J Affect Disord; 2013 Sep; 150(3):829-33. PubMed ID: 23706841
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
[TBL] [Abstract][Full Text] [Related]
15. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase and arylesterase activities in patients with chronic otitis media.
Turan M; Ucler R; Aslan M; Kalkan F; Taskın A; Garca MF; Cankaya H
Redox Rep; 2015; 20(6):241-5. PubMed ID: 25968808
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
Verit FF; Celik H; Yazgan P; Erel O; Geyikli I
Arch Gynecol Obstet; 2007 May; 275(5):353-9. PubMed ID: 17086419
[TBL] [Abstract][Full Text] [Related]
19. Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer.
Arioz DT; Camuzcuoglu H; Toy H; Kurt S; Celik H; Erel O
Eur J Gynaecol Oncol; 2009; 30(6):679-82. PubMed ID: 20099504
[TBL] [Abstract][Full Text] [Related]
20. Acetaminophen intoxication is associated with decreased serum paraoxonase and arylesterase activities and increased lipid hydroperoxide levels.
Karadas S; Aslan M; Gonullu H; Kati C; Duran L; Olmez S; Kucukoglu ME; Demir H
Hum Exp Toxicol; 2014 Nov; 33(11):1134-40. PubMed ID: 24501102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
